<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02406703</url>
  </required_header>
  <id_info>
    <org_study_id>BLV07</org_study_id>
    <nct_id>NCT02406703</nct_id>
  </id_info>
  <brief_title>The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Regionale Bellinzona e Valli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Regionale Bellinzona e Valli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background and Objectives Short acting regional anesthetics have already been successfully
      employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on
      direct and indirect perioperative costs comparing two different short-acting local
      anesthetics has not been performed, yet.

      Methods In an observational study including 50 patients per group, patient undergoing
      popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery
      were compared. The primary outcome was the saving of both direct and indirect perioperative
      costs. Secondary outcomes were block success, onset time and block duration, patient
      satisfaction and unplanned outpatient visits or readmissions after discharge.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cost minimization analysis</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Impact of Anesthetic Choice on Costs</condition>
  <arm_group>
    <arm_group_label>Chloroprocaine</arm_group_label>
    <description>Patient undergoing popliteal block with chloroprocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mepivacaine</arm_group_label>
    <description>Patient undergoing popliteal block with mepivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chloroprocaine</intervention_name>
    <arm_group_label>Chloroprocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivacaine</intervention_name>
    <arm_group_label>Mepivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery (percutaneous
        hallux valgus correction, osteotomies, tenotomies, mallet and hammer toes correction,
        screws and/or plaques removal)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery
             (percutaneous hallux valgus correction, osteotomies, tenotomies, mallet and hammer
             toes correction, screws and/or plaques removal)

        Exclusion Criteria:

          -  known allergy to drugs used in the study;

          -  coagulopathies, known neuropathy;

          -  pregnancy;

          -  chronic pain;

          -  drug or alcohol abuse;

          -  psychiatric disease or lack of competence affecting compliance and evidence of ongoing
             sepsis or local skin / subcutaneous tissues infections in the popliteal fossa.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2015</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Regionale Bellinzona e Valli</investigator_affiliation>
    <investigator_full_name>Andrea Saporito</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>local anesthesia</keyword>
  <keyword>regional anesthetic</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>Chloroprocaine</mesh_term>
    <mesh_term>Procaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

